AGENUS INC Logo

AGENUS INC

A clinical-stage biotechnology company specializing in immuno-oncology therapies.

AGEN | US

Overview

Corporate Details

ISIN(s):
US00847G8042
LEI:
Country:
United States of America
Address:
3 FORBES ROAD, 2421 LEXINGTON

Description

Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 17:05
4
English ZIP 7.7 KB
2025-12-01 17:05
4
English ZIP 7.7 KB
2025-11-17 17:05
4
English ZIP 7.7 KB
2025-11-10 18:12
10-Q
English ZIP 2.0 MB
2025-11-10 08:32
8-K
English ZIP 284.3 KB
2025-11-05 17:05
4
English ZIP 7.7 KB
2025-10-30 15:24 English ZIP 8.1 KB
2025-10-21 18:05
4
English ZIP 7.7 KB
2025-10-09 18:05
8-K
English ZIP 52.2 KB
2025-10-06 18:05
4
English ZIP 7.7 KB
2025-10-03 18:05
4
English ZIP 6.8 KB
2025-10-03 18:05
4
English ZIP 7.3 KB
2025-09-23 19:12
8-K
English ZIP 49.6 KB
2025-09-23 18:05
4
English ZIP 7.7 KB
2025-09-09 18:05
4
English ZIP 7.7 KB

Automate Your Workflow. Get a real-time feed of all AGENUS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AGENUS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AGENUS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AMARIN CORP PLC\UK Logo
Develops and commercializes therapeutics to improve cardiovascular health.
United States of America
AMRN
AMGEN INC Logo
A biotechnology company developing human therapeutics for serious illnesses.
United States of America
AMGN
Industrial biotechnology company specializing in specialty enzymes and proteins.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Biotechnology company developing therapies for rare genetic and devastating diseases.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Specialty manufacturer of high-purity chiral amino acids and their derivatives.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops, manufactures, and distributes generic and specialty pharmaceuticals.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops, manufactures, and markets technically challenging medications.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Develops therapies for neurodegenerative diseases and other unmet medical needs.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Biopharmaceutical firm developing boron-based drugs for infectious diseases.
United States of America
ANTX
Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.